Definition for the Assessment of Time-to-event Endpoints in CANcer Trials (DATECAN-1)

Conditions

• Cancer

Interventions

• OTHER: Sarcoma and GIST
• OTHER: Breast cancer
• OTHER: Pancreatic cancer
• OTHER: Renal cell carcinoma
• OTHER: Colon cancer
• OTHER: Solid tumours undergoing image-guided tumor ablation
• OTHER: (early) Non Small Cell Lung Cancer

Sponsor

Institut Bergonié

Collaborators

• [object Object]
• [object Object]
• [object Object]